Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor


Cetin B., Kaplan M. A. , Berk V., Tufan G., Benekli M., Isikdogan A., ...More

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol.43, no.1, pp.28-32, 2013 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 1
  • Publication Date: 2013
  • Doi Number: 10.1093/jjco/hys175
  • Title of Journal : JAPANESE JOURNAL OF CLINICAL ONCOLOGY
  • Page Numbers: pp.28-32

Abstract

Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns and controversies remain over combining cytotoxic chemotherapy with bevacizumab in this patient population.